Many stars must align for a university research project to turn into a successful independent business. Just ask Northeastern alumnus Joel Berniac, the chief executive officer and co-founder of Akrivis Technologies, a life sciences company committed to commercializing research from the lab of Northeastern professor of pharmaceutical sciences Ban-An Khaw.
Akrivis has developed a medical device that can detect the presence of diseases like cancer earlier than existing methods. It uses blood tests capable of detecting biomarkers at very low concentrations and imaging techniques capable of visualizing millimeter-size tumor lesions. The company has raised nearly $750,000 since its founding in 2009 and late last year moved its headquarters from a high-tech business incubator to new lab space in the Salem, Mass., headquarters of US Biological, now a strategic and distribution partner of Akrivis.